Abstract: The frontier of precision medicine is shifting from what our genes say to how our environments talk to our genes. Backed by a £16 million investment from the Novo Nordisk Foundation and technological support from Illumina, the University of Exeter is launching a landmark study to map epigenetic variations across the UK Biobank’s massive repository. By profiling DNA methylation, the chemical “on/off” switches shaped by lifestyle and environment, at over one million genomic sites in blood samples from 60,000 participants, this initiative aims to add an unprecedented layer of functional data to the world’s most comprehensive biomedical database.
What makes this project transformative for global health research is its focus on the biological mechanics of everyday life. Epigenetics sits directly at the interface of nature and nurture, meaning researchers will finally have the statistical power to track exactly how factors like pollution, chronic stress, diet, and smoking physically embed themselves into our molecular biology to trigger conditions like dementia, cancer, and heart disease. By integrating these new epigenetic maps with the UK Biobank’s existing wealth of proteomic, imaging, and electronic health data, the initiative is positioned to fast-track the discovery of early blood-based biomarkers. This will effectively shift public healthcare infrastructure away from reactive treatment and toward true, preventative personalized medicine.
Found interesting, read more here: https://news.exeter.ac.uk/faculty-of-health-and-life-sciences/landmark-uk-biobank-epigenetics-study-will-reveal-impact-of-genes-and-environment-on-health/
